The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Intramuscular Injectable Suspensions-Global Market Insights and Sales Trends 2024

Intramuscular Injectable Suspensions-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1869163

No of Pages : 106

Ask Your Query
Synopsis
The global Intramuscular Injectable Suspensions market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Intramuscular Injectable Suspensions in various end use industries. The expanding demands from the Hospitals Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Intramuscular Injectable Suspensions market. Single-Dose Injections, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Multiple-Dose Injections segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Intramuscular Injectable Suspensions market, driven by demand from China, the second largest economy with some signs of stabilising, the Intramuscular Injectable Suspensions market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intramuscular Injectable Suspensions, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intramuscular Injectable Suspensions market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intramuscular Injectable Suspensions market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intramuscular Injectable Suspensions sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intramuscular Injectable Suspensions covered in this report include Merck Sharp & Dohme, Novo Nordisk, Lilly, Biocon Limited, Pfizer, BeiGene, EnteraBio, AbbVie and Pfizer Limited, etc.
The global Intramuscular Injectable Suspensions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Sharp & Dohme
Novo Nordisk
Lilly
Biocon Limited
Pfizer
BeiGene
EnteraBio
AbbVie
Pfizer Limited
Teva Pharmaceuticals USA
Bristol-Myers Squibb
Cipla
Baxter International
AstraZeneca
Global Intramuscular Injectable Suspensions market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intramuscular Injectable Suspensions market, Segment by Type:
Single-Dose Injections
Multiple-Dose Injections
Global Intramuscular Injectable Suspensions market, by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intramuscular Injectable Suspensions manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intramuscular Injectable Suspensions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Intramuscular Injectable Suspensions Market Overview
1.1 Intramuscular Injectable Suspensions Product Overview
1.2 Intramuscular Injectable Suspensions Market Segment by Type
1.2.1 Single-Dose Injections
1.2.2 Multiple-Dose Injections
1.3 Global Intramuscular Injectable Suspensions Market Size by Type
1.3.1 Global Intramuscular Injectable Suspensions Market Size Overview by Type (2018-2029)
1.3.2 Global Intramuscular Injectable Suspensions Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intramuscular Injectable Suspensions Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intramuscular Injectable Suspensions Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intramuscular Injectable Suspensions Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intramuscular Injectable Suspensions Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intramuscular Injectable Suspensions Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intramuscular Injectable Suspensions Sales Breakdown by Type (2018-2023)
2 Global Intramuscular Injectable Suspensions Market Competition by Company
2.1 Global Top Players by Intramuscular Injectable Suspensions Sales (2018-2023)
2.2 Global Top Players by Intramuscular Injectable Suspensions Revenue (2018-2023)
2.3 Global Top Players by Intramuscular Injectable Suspensions Price (2018-2023)
2.4 Global Top Manufacturers Intramuscular Injectable Suspensions Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intramuscular Injectable Suspensions Market Competitive Situation and Trends
2.5.1 Intramuscular Injectable Suspensions Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intramuscular Injectable Suspensions Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intramuscular Injectable Suspensions as of 2022)
2.7 Date of Key Manufacturers Enter into Intramuscular Injectable Suspensions Market
2.8 Key Manufacturers Intramuscular Injectable Suspensions Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intramuscular Injectable Suspensions Status and Outlook by Region
3.1 Global Intramuscular Injectable Suspensions Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intramuscular Injectable Suspensions Historic Market Size by Region
3.2.1 Global Intramuscular Injectable Suspensions Sales in Volume by Region (2018-2023)
3.2.2 Global Intramuscular Injectable Suspensions Sales in Value by Region (2018-2023)
3.2.3 Global Intramuscular Injectable Suspensions Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intramuscular Injectable Suspensions Forecasted Market Size by Region
3.3.1 Global Intramuscular Injectable Suspensions Sales in Volume by Region (2024-2029)
3.3.2 Global Intramuscular Injectable Suspensions Sales in Value by Region (2024-2029)
3.3.3 Global Intramuscular Injectable Suspensions Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intramuscular Injectable Suspensions by Application
4.1 Intramuscular Injectable Suspensions Market Segment by Application
4.1.1 Hospitals Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Intramuscular Injectable Suspensions Market Size by Application
4.2.1 Global Intramuscular Injectable Suspensions Market Size Overview by Application (2018-2029)
4.2.2 Global Intramuscular Injectable Suspensions Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intramuscular Injectable Suspensions Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intramuscular Injectable Suspensions Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intramuscular Injectable Suspensions Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intramuscular Injectable Suspensions Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intramuscular Injectable Suspensions Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intramuscular Injectable Suspensions Sales Breakdown by Application (2018-2023)
5 North America Intramuscular Injectable Suspensions by Country
5.1 North America Intramuscular Injectable Suspensions Historic Market Size by Country
5.1.1 North America Intramuscular Injectable Suspensions Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intramuscular Injectable Suspensions Sales in Volume by Country (2018-2023)
5.1.3 North America Intramuscular Injectable Suspensions Sales in Value by Country (2018-2023)
5.2 North America Intramuscular Injectable Suspensions Forecasted Market Size by Country
5.2.1 North America Intramuscular Injectable Suspensions Sales in Volume by Country (2024-2029)
5.2.2 North America Intramuscular Injectable Suspensions Sales in Value by Country (2024-2029)
6 Europe Intramuscular Injectable Suspensions by Country
6.1 Europe Intramuscular Injectable Suspensions Historic Market Size by Country
6.1.1 Europe Intramuscular Injectable Suspensions Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intramuscular Injectable Suspensions Sales in Volume by Country (2018-2023)
6.1.3 Europe Intramuscular Injectable Suspensions Sales in Value by Country (2018-2023)
6.2 Europe Intramuscular Injectable Suspensions Forecasted Market Size by Country
6.2.1 Europe Intramuscular Injectable Suspensions Sales in Volume by Country (2024-2029)
6.2.2 Europe Intramuscular Injectable Suspensions Sales in Value by Country (2024-2029)
7 Asia-Pacific Intramuscular Injectable Suspensions by Region
7.1 Asia-Pacific Intramuscular Injectable Suspensions Historic Market Size by Region
7.1.1 Asia-Pacific Intramuscular Injectable Suspensions Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intramuscular Injectable Suspensions Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intramuscular Injectable Suspensions Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intramuscular Injectable Suspensions Forecasted Market Size by Region
7.2.1 Asia-Pacific Intramuscular Injectable Suspensions Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intramuscular Injectable Suspensions Sales in Value by Region (2024-2029)
8 Latin America Intramuscular Injectable Suspensions by Country
8.1 Latin America Intramuscular Injectable Suspensions Historic Market Size by Country
8.1.1 Latin America Intramuscular Injectable Suspensions Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intramuscular Injectable Suspensions Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intramuscular Injectable Suspensions Sales in Value by Country (2018-2023)
8.2 Latin America Intramuscular Injectable Suspensions Forecasted Market Size by Country
8.2.1 Latin America Intramuscular Injectable Suspensions Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intramuscular Injectable Suspensions Sales in Value by Country (2024-2029)
9 Middle East and Africa Intramuscular Injectable Suspensions by Country
9.1 Middle East and Africa Intramuscular Injectable Suspensions Historic Market Size by Country
9.1.1 Middle East and Africa Intramuscular Injectable Suspensions Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intramuscular Injectable Suspensions Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intramuscular Injectable Suspensions Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intramuscular Injectable Suspensions Forecasted Market Size by Country
9.2.1 Middle East and Africa Intramuscular Injectable Suspensions Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intramuscular Injectable Suspensions Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck Sharp & Dohme
10.1.1 Merck Sharp & Dohme Company Information
10.1.2 Merck Sharp & Dohme Introduction and Business Overview
10.1.3 Merck Sharp & Dohme Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Sharp & Dohme Intramuscular Injectable Suspensions Products Offered
10.1.5 Merck Sharp & Dohme Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novo Nordisk Intramuscular Injectable Suspensions Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Lilly
10.3.1 Lilly Company Information
10.3.2 Lilly Introduction and Business Overview
10.3.3 Lilly Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lilly Intramuscular Injectable Suspensions Products Offered
10.3.5 Lilly Recent Development
10.4 Biocon Limited
10.4.1 Biocon Limited Company Information
10.4.2 Biocon Limited Introduction and Business Overview
10.4.3 Biocon Limited Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biocon Limited Intramuscular Injectable Suspensions Products Offered
10.4.5 Biocon Limited Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Intramuscular Injectable Suspensions Products Offered
10.5.5 Pfizer Recent Development
10.6 BeiGene
10.6.1 BeiGene Company Information
10.6.2 BeiGene Introduction and Business Overview
10.6.3 BeiGene Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BeiGene Intramuscular Injectable Suspensions Products Offered
10.6.5 BeiGene Recent Development
10.7 EnteraBio
10.7.1 EnteraBio Company Information
10.7.2 EnteraBio Introduction and Business Overview
10.7.3 EnteraBio Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.7.4 EnteraBio Intramuscular Injectable Suspensions Products Offered
10.7.5 EnteraBio Recent Development
10.8 AbbVie
10.8.1 AbbVie Company Information
10.8.2 AbbVie Introduction and Business Overview
10.8.3 AbbVie Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AbbVie Intramuscular Injectable Suspensions Products Offered
10.8.5 AbbVie Recent Development
10.9 Pfizer Limited
10.9.1 Pfizer Limited Company Information
10.9.2 Pfizer Limited Introduction and Business Overview
10.9.3 Pfizer Limited Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pfizer Limited Intramuscular Injectable Suspensions Products Offered
10.9.5 Pfizer Limited Recent Development
10.10 Teva Pharmaceuticals USA
10.10.1 Teva Pharmaceuticals USA Company Information
10.10.2 Teva Pharmaceuticals USA Introduction and Business Overview
10.10.3 Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Products Offered
10.10.5 Teva Pharmaceuticals USA Recent Development
10.11 Bristol-Myers Squibb
10.11.1 Bristol-Myers Squibb Company Information
10.11.2 Bristol-Myers Squibb Introduction and Business Overview
10.11.3 Bristol-Myers Squibb Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bristol-Myers Squibb Intramuscular Injectable Suspensions Products Offered
10.11.5 Bristol-Myers Squibb Recent Development
10.12 Cipla
10.12.1 Cipla Company Information
10.12.2 Cipla Introduction and Business Overview
10.12.3 Cipla Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Cipla Intramuscular Injectable Suspensions Products Offered
10.12.5 Cipla Recent Development
10.13 Baxter International
10.13.1 Baxter International Company Information
10.13.2 Baxter International Introduction and Business Overview
10.13.3 Baxter International Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Baxter International Intramuscular Injectable Suspensions Products Offered
10.13.5 Baxter International Recent Development
10.14 AstraZeneca
10.14.1 AstraZeneca Company Information
10.14.2 AstraZeneca Introduction and Business Overview
10.14.3 AstraZeneca Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2018-2023)
10.14.4 AstraZeneca Intramuscular Injectable Suspensions Products Offered
10.14.5 AstraZeneca Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intramuscular Injectable Suspensions Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intramuscular Injectable Suspensions Industrial Chain Analysis
11.4 Intramuscular Injectable Suspensions Market Dynamics
11.4.1 Intramuscular Injectable Suspensions Industry Trends
11.4.2 Intramuscular Injectable Suspensions Market Drivers
11.4.3 Intramuscular Injectable Suspensions Market Challenges
11.4.4 Intramuscular Injectable Suspensions Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intramuscular Injectable Suspensions Distributors
12.3 Intramuscular Injectable Suspensions Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock